The effect of raloxifene augmentation in men and women with a schizophrenia spectrum disorder: a systematic review and meta-analysis

Recognizing the robust sex differences in schizophrenia prevalence, the selective estrogen receptor modulator (SERM) raloxifene is a likely candidate for augmentation therapy in this disorder. Therefore, a systematic search was performed using PubMed (Medline), Embase, PsychInfo, and Cochrane Databa...

Descripción completa

Detalles Bibliográficos
Autores principales: de Boer, Janna, Prikken, Merel, Lei, Wan U., Begemann, Marieke, Sommer, Iris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762671/
https://www.ncbi.nlm.nih.gov/pubmed/29321530
http://dx.doi.org/10.1038/s41537-017-0043-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762671/
https://www.ncbi.nlm.nih.gov/pubmed/29321530
http://dx.doi.org/10.1038/s41537-017-0043-3

Ejemplares similares